APA (7th ed.) Citation

Gomez-Roca, C., Fons, P., Ancey, P., Cassier, P., Delord, J., Davenne, L., . . . Rochaix, P. (2023). 137P VEGFR-3 expression profiling by histology and mRNA signature to classify patient population for the selective VEGFR-3 inhibitor EVT801. Annals of Oncology, 34, S235. https://doi.org/10.1016/j.annonc.2023.09.2862

Chicago Style (17th ed.) Citation

Gomez-Roca, C.A, et al. "137P VEGFR-3 Expression Profiling by Histology and MRNA Signature to Classify Patient Population for the Selective VEGFR-3 Inhibitor EVT801." Annals of Oncology 34 (2023): S235. https://doi.org/10.1016/j.annonc.2023.09.2862.

MLA (9th ed.) Citation

Gomez-Roca, C.A, et al. "137P VEGFR-3 Expression Profiling by Histology and MRNA Signature to Classify Patient Population for the Selective VEGFR-3 Inhibitor EVT801." Annals of Oncology, vol. 34, 2023, p. S235, https://doi.org/10.1016/j.annonc.2023.09.2862.